LeMaitre Vascular, Inc.
LMAT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $219,863 | $193,484 | $161,651 | $154,424 |
| % Growth | 13.6% | 19.7% | 4.7% | – |
| Cost of Goods Sold | $68,962 | $66,435 | $56,755 | $53,042 |
| Gross Profit | $150,901 | $127,049 | $104,896 | $101,382 |
| % Margin | 68.6% | 65.7% | 64.9% | 65.7% |
| R&D Expenses | $15,650 | $16,966 | $13,294 | $11,801 |
| G&A Expenses | $36,258 | $31,832 | $28,745 | $25,501 |
| SG&A Expenses | $82,995 | $72,886 | $61,666 | $53,156 |
| Sales & Mktg Exp. | $46,737 | $41,054 | $32,921 | $27,655 |
| Other Operating Expenses | $0 | $485 | $3,107 | $0 |
| Operating Expenses | $98,645 | $90,337 | $78,067 | $64,957 |
| Operating Income | $52,256 | $36,712 | $26,829 | $36,425 |
| % Margin | 23.8% | 19% | 16.6% | 23.6% |
| Other Income/Exp. Net | $4,619 | $2,763 | $661 | -$2,138 |
| Pre-Tax Income | $56,875 | $39,475 | $27,490 | $34,287 |
| Tax Expense | $12,837 | $9,370 | $6,854 | $7,380 |
| Net Income | $44,038 | $30,105 | $20,636 | $26,907 |
| % Margin | 20% | 15.6% | 12.8% | 17.4% |
| EPS | 1.96 | 1.36 | 0.94 | 1.27 |
| % Growth | 44.1% | 44.7% | -26% | – |
| EPS Diluted | 1.93 | 1.34 | 0.93 | 1.25 |
| Weighted Avg Shares Out | 22,452 | 22,217 | 21,975 | 21,157 |
| Weighted Avg Shares Out Dil | 22,779 | 22,423 | 22,171 | 21,475 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4,949 | $3,077 | $986 | $197 |
| Interest Expense | $205 | $0 | $0 | $2,219 |
| Depreciation & Amortization | $9,670 | $9,515 | $9,433 | $9,475 |
| EBITDA | $66,750 | $48,990 | $36,923 | $45,981 |
| % Margin | 30.4% | 25.3% | 22.8% | 29.8% |